Life Time's Oct. 25 nationwide fundraiser for ALS research challenges participants to work out for 90 minutes.
It took time for Philip to discover acceptance was key to him for living with ALS. Learn about his journey from diagnosis to ...
Although the exact causes of ALS remain unknown, both genetic and environmental factors may contribute to its development.
A Phase 3 clinical trial testing pridopidine in people with ALS is expected to start enrolling patients in January.
An AI model used seven common clinical measures of inflammation, nutritional status, and more to predict ALS prognosis, a ...
Northwestern University professor Hande Ozdinler is hoping to change how ALS is treated, saying the disease is too complex ...
Advocates in Canada are urging their federal government to invest more in ALS research and trial opportunities.
FGF21, a hormone that helps cells regulate energy use and respond to stress, may protect muscles and nerve cells from damage ...
Researchers identified three subtypes of amyotrophic lateral sclerosis, each with distinct mechanisms that could be future ...
Building an online store has given columnist Kristin Neva and her husband, Todd, a project to work on together.
Faced with a rapidly progressing form of ALS, Iomar Barrett describes the disease trajectory that's less common on social ...
ALS patients seem to have immune cells that attack the C9ORF72 protein in nerve cells, suggesting ALS may be an autoimmune disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results